title: Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors.
abstract: Intraventricular cholecystokinin COOH-terminal octapeptide (CCK-8) decreases meal size in the meal-trained baboon. In the present study, we tested whether this action is mediated by CCK-A receptors, CCK-B receptors, or both. Intraventricular administration of the selective CCK-A receptor agonist A71623 at 1 and 10 nmol/kg suppressed 30-min meal size 69 +/- 22% and 75 +/- 7%, respectively. Additionally, intraventricular A71623 was equipotent to CCK-8 at 1 nmol/kg (% suppression of meal by CCK = 59 +/- 17). However, intraventricular administration of the CCK-B receptor agonist A63387 at 10 nmol/kg had no effect on 30-min meal size (% suppression = 18 +/- 29). Intravenous administration of 10 nmol/kg A71623 did not result in an alteration of meal size, but prandial plasma insulin and glucose responses were delayed and blunted. Basal plasma insulin levels doubled after intravenous administration of A71623. Both behavioral and metabolic responses to A71623 in the baboon are virtually identical to those we have previously observed after CCK-8 treatment. Thus we conclude that the predominant receptor population with which intraventricular CCK-8 interacts are type-A CCK receptors that are accessible to the ventricular system of the baboon.
authors.affiliation: Department of Psychology, University of Washington, Seattle 98195.
authors.forename: D P
authors.initials: DP
authors.lastname: Figlewicz
authors.forename: A M
authors.initials: AM
authors.lastname: Nadzan
authors.forename: A J
authors.initials: AJ
authors.lastname: Sipols
authors.forename: P K
authors.initials: PK
authors.lastname: Green
authors.forename: R A
authors.initials: RA
authors.lastname: Liddle
authors.forename: D
authors.initials: D
authors.lastname: Porte
authors.forename: S C
authors.initials: SC
authors.lastname: Woods
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002766:Cholecystokinin / Q000097:blood; D004435:Eating / Q000187:drug effects*; D005215:Fasting; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology; D010215:Papio; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000502:physiology*; D012844:Sincalide / Q000494:pharmacology*; D013758:Tetragastrin / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D001786:Blood Glucose; D007328:Insulin; D009842:Oligopeptides; D011949:Receptors, Cholecystokinin; D013758:Tetragastrin; C066278:A 71623; C075264:A 63387; D002766:Cholecystokinin; D012844:Sincalide